Article
Structure-based virtual screening of natural compounds against wild and mutant (R1155K, A1156T and D1168A) NS3-4A protease of Hepatitis C virus.
Journal of biomolecular structure & dynamics - 1 Oct 2024
Samantaray Mahesh, Pattabiraman Ramya, Murthy T P Krishna, Ramaswamy Amutha, Murahari Manikanta, Krishna Swati, Kumar S Birendra
Abstract excerpt
NS3-4A, a serine protease, is a primary target for drug development against Hepatitis C Virus (HCV). However, the effectiveness of potent next-generation protease inhibitors is limited by the emergence of mutations and resulting drug resistance. To address this, in this study a structure-based drug design approach is employed to screen a large library of 7320 natural compounds against both wild-type and mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
